Zobrazeno 1 - 10
of 129
pro vyhledávání: '"Björn Wiman"'
Autor:
Björn Wiman
Publikováno v:
Moderna Språk, Vol 88, Iss 2 (1994)
Externí odkaz:
https://doaj.org/article/008888e40cbf45c7975a8e7544a587e7
Autor:
Gordon K. Wilcock, Patrick G. Kehoe, Boo Johansson, Hagit Katzov, Björn Wiman, Jonathan A. Prince, Lars Feuk, Anthony J. Brookes, Kaj Blennow, Anna M. Bennet, Nigel J. Cairns, Ulf de Faire
Numerous genes have been implicated in Alzheimer's disease (AD), but, with the exception of a demonstrated association with the epsilon 4 allele of APOE, findings have not been consistently replicated across populations. One of the most widely studie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca896476d3c5a6cae291d4f93f7ce159
https://doi.org/10.1093/hmg/ddg094
https://doi.org/10.1093/hmg/ddg094
Publikováno v:
Thrombosis Research. 127:47-50
Introduction There is a need for more reliable methods measuring the binding of coagulation factor VIII (FVIII) to von Willebrand factor (VWF) in plasma samples, for use in the clinical routine. We have developed such a method measuring FVIII binding
Publikováno v:
Journal of Internal Medicine. 264:586-592
High plasminogen activator inhibitor type 1 (PAI-1) activity is associated with inflammatory reactions and insulin resistance, but it is unclear what regulates PAI-1 activity at the low end. The purpose of this study was to investigate if patients wi
Autor:
Björn Wiman, Gurdeep S. Sagoo, Merel van Maarle, John J.P. Kastelein, Iain Tatt, Julian P T Higgins, Adam S. Butterworth, J. Wouter Jukema, Georgia Salanti, Anna M. Bennet, Danesh J, Ulf de Faire, Nadeem Sarwar
Publikováno v:
American Journal of Epidemiology. 168:1233-1246
Lipoprotein lipase (LPL) is a key enzyme in lipoprotein metabolism and a major candidate gene for coronary heart disease (CHD). The authors assessed associations between 7 LPL polymorphisms and lipid fractions and CHD risk in population-based cohort,
Publikováno v:
Blood Coagulation & Fibrinolysis. 18:657-660
Low activity of plasminogen activator inhibitor type 1 (PAI-1) has been associated with bleeding complications in surgery. We earlier reported a higher prevalence of low PAI-1 activity among patients with bleeding tendency as compared with normal con
Publikováno v:
Thrombosis Research. 119:715-721
Introduction Low levels of plasminogen activator inhibitor type 1 (PAI-1) have been associated with increased risk for perioperative bleeding in some case reports. The aim of this study was to investigate prospectively whether low PAI-1 activity incr
The interaction between plasminogen and antiplasmin variants as studied by surface plasmon resonance
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1764:1730-1734
The interaction between immobilized plasminogen or an elastase-degradation product from plasminogen, constituting “kringles” 1–3 and different purified variants of antiplasmin has been studied by surface plasmon resonance utilising a BIAcore. T
Autor:
Ulf de Faire, Björn Wiman, Anna M. Bennet, Ludmila Prokunina-Olsson, Marta E. Alarcón-Riquelme
Publikováno v:
Human Immunology. 67:700-705
Increasing interest has been directed toward the inflammatory mechanisms involved in the pathogenesis of myocardial infarction (MI). In the search for genetic mechanisms underlying these inflammatory components, we studied variants of programmed cell
Association of TNF-α serum levels and TNFA promoter polymorphisms with risk of myocardial infarction
Autor:
Johan Hallqvist, Johan Frostegård, Jonathan A. Prince, Björn Wiman, U de Faire, M. Van Maarle, Ralf Morgenstern, Anna M. Bennet
Publikováno v:
Atherosclerosis, 187(2), 408-414. Elsevier Ireland Ltd
Elevated levels of tumor necrosis factor-alpha (TNF-alpha), and presence of polymorphisms of the TNFA gene have been implicated in cardiovascular disease pathogenesis. We explored the relationship between polymorphisms in the TNFA gene (-1031C/T, -86